Objective. To evaluate the long-term effects of the angiotensin converting enzyme inhibitor enalapril and of the angiotensin II type 1 receptor antagonist losartan on the angiotensin converting enzyme activity in T-lymphocytes and on the proliferation of peripheral blood mononuclear cells (PBMC) in patients with essential hypertension.
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The possible contributions of the angiotensin receptor subtypes 1 (AT 1 ) and 2 (AT 2 ) on the angiotensin II-induced collagen gel contraction by adult rat cardiac fibroblasts were studied using the specific angiotensin receptor AT 1 and AT 2 antagonists telmisartan and P-186, respectively.
Cardiac fibroblasts (from normal male adult rats) from passage 2 were cultured to confluency and added to a hydrated collagen gel, with or without angiotensin II (ANGII), angiotensin II plus telmisartan or angiotensin II plus P-186 in Dulbecco's MEM medium containing 5 % foetal bovine serum for 1, 2 or 3 days.
Control gels containing adult rat cardiac fibroblasts showed a significant amount of contraction after 3 days of incubation, causing a contraction to 67.9 Ϯ 7.1 % of the area after 1 day. ANGII (10 -7 M) stimulated (p Ͻ 0.05 or less) the contraction of collagen mediated by cardiac fibroblasts after 1, 2 or 3 days. Telmisartan (10 -7 M) completely blocked the ANGII-induced collagen contraction by cardiac fibroblasts. P-186 (10 -7 M) had no effect on the ANGII-induced collagen contraction by cardiac fibroblasts. Addition of telmisartan and P-186 alone did not affect the collagen gel contraction by cardiac fibroblasts.
Our data demonstrate that the effects of ANGII on the collagen gel contraction by adult rat cardiac fibroblasts are AT 1 -receptor mediated because they were abolished by the specific AT 1 -receptor antagonist telmisartan but not by the specific AT 2 -receptor antagonist P-186. The possible contributions of the angiotensin receptor subtypes 1 (AT 1 ) and 2 (AT 2 ) on the angiotensin II-induced changes in collagen secretion and production were studied using the specific angiotensin receptor AT 1 and AT 2 antagonists telmisartan and P-186, respectively. Cardiac fibroblasts (from normal male adult rats) from passage 2 were cultured to confluency and incubated in the presence of angiotensin II (ANGII) in a concentration range of 10 -10 to 10 -6 M for 24 hours in Dulbecco's MEM medium. The collagen production and secretion were assayed by 3 HProline incorporation, the non-collagen production and secretion were also calculated.
ANGII dose-dependently increases the collagen secretion and production in rat adult cardiac fibroblasts in culture. The non-collagen secretion and production were also concentration-dependently increased by AN-GII. Addition of 100 nmol/l ANGII increases (p Ͻ 0.01) the collagen secretion and production by 75 Ϯ 6 (SEM) % and 113 Ϯ 23 %, respectively and the non-collagen secretion and production by 65 Ϯ 6 % and 57 Ϯ 16 %, respectively.
Pretreatment of cardiac fibroblasts with telmisartan completely blocks the ANGII-induced increase in collagen secretion (p Ͻ 0.001) and production (p Ͻ 0.05) and in non-collagen secetion (p Ͻ 0.01) and production (p Ͻ 0.01). P-186 has no effect on the ANGII-induced increase in collagen secretion and production. Addition of telmisartan and P-186 does not affect the collagen secretion and production in basal fibroblasts.
Our data demonstrate that the effects of ANGII on (non)collagen secretion and production in adult rat cardiac fibroblasts in culture are AT 1 -receptor mediated because they were abolished by the specific AT 1 -receptor antagonist telmisartan but not by the specific AT 2 -receptor antagonist P-186. The mitogen Angiotensin II (AII) that binds to specific G-protein coupled receptors, plays an important role in human disease as the distal effector of the renin-angiotensin system. AII is mitogenic in adrenal, liver epithelial, and vascular smooth muscle cells. Many of the known biological actions of AII including enhanced DNA synthesis are mediated by stimulation of the AT1 receptor which is a member of the G proteincoupled seven transmembrane spanning receptor family. AT1 receptor activation through phospholipase C initiates a rapid release of inositol
